Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hellerup
Clinical trial register · Denmark

Clinical Trials in Hellerup, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Tor Biering-Sørensen9 Herlev and Gentofte Hospital8 University Hospital, Gentofte, Copenhagen8 Novo Nordisk A/S5 Bristol-Myers Squibb4
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Hellerup

77 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Hellerup, Aarhus, Odense C, Copenhagen
2026-12-16
Not yet open
THERMotherapy Against Persistent Bacterial LUNG Infections
NCT05351242Lung Diseases, Obstructive, Bronchiectasis, Asthma, Copd
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Not applicable
150
Hellerup
2026-10-01
Not yet open
Tor Biering-Sørensen
Phase 4
410,000
Hellerup, Søborg
2026-09-01
Not yet open
Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial
NCT07382414Ischemic Heart Disease, Coronary Artery Disease, Hypercholesterolemia, Lipoprotein(a)
Tor Biering-Sørensen
Not applicable
123,000
Hellerup
2026-09
Recruiting
Novo Nordisk A/S
Phase 3
450
Aarhus N, Hellerup, Herning
2026-08-12
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Aarhus, Copenhagen, Hellerup, Odense C
2026-06-11
By invitation
University of Copenhagen
Not applicable
14
Hellerup
2026-05-19
Active, closed
Tor Biering-Sørensen
Phase 4
168,460
Hellerup, Søborg
2026-04-28
Recruiting
University Hospital, Gentofte, Copenhagen
Not applicable
18
Hellerup
2026-04
Recruiting
Copenhagen Respiratory Research
Phase 4
1,600
Rønne, Copenhagen, Frederiksberg, Hellerup, Herlev, Hvidovre, Hillerød, Holbæk
2026-03-10
Recruiting
Copenhagen Respiratory Research
Phase 4
2,000
Rønne, Copenhagen, Frederiksberg, Hellerup, Herlev, Hvidovre, Hillerød, Holbæk
2026-03-10
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Vejle, Gandrup, Gistrup, Hellerup, Hillerød, Hvidovre
2026-02-24
By invitation
Celldex Therapeutics
Phase 3
1,370
Aarhus N, Hellerup
2025-11-25
Recruiting
UCB Biopharma SRL
Phase 3
320
Hellerup
2025-11-14
Recruiting
Incyte Corporation
Phase 3
250
Hellerup, Herlev
2025-11-13
Active, closed
Methotrexat to Hand Eczema in the BIOSKIN Cohort
NCT07338305Atopic Dermatitis, Contact Dermatitis, Hand Eczema
Lone Skov
Observational
50
Hellerup
2025-11-01
Recruiting
Acesion Pharma
Phase 2
200
Hellerup, Viborg
2025-10-22
Active, closed
Treatment of Bile Acid Diarrhoea With Atorvastatin
NCT07042165Bile Acid Diarrhea, Bile Acid Malabsorption
DrugAtorvastatin
Asger Lund, MD
Phase 4
20
Hellerup
2025-10-15
Recruiting
Tor Biering-Sørensen
Phase 3
4,044
Hellerup
2025-09-30
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Copenhagen, Aalborg, Aarhus, Hellerup, Herlev
2025-09-22
Active, closed
University Hospital, Gentofte, Copenhagen
Not applicable
28
Hellerup
2025-05-01
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Aalborg, Aarhus, Hellerup, København NV, Odense, Roskilde
2025-04-15
Active, closed
Amgen
Phase 3
3,853
Gandrup, Hellerup, Herlev, Herning, Hvidovre
2025-03-12
Not yet open
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial
NCT06856772Cardiovascular Diseases (CVD), Drug Effect, Atherosclerosis Cardiovascular Disease
Tor Biering-Sørensen
Phase 4
42,000
Hellerup
2025-02-28
Recruiting
Copenhagen Heart Failure With Preserved Ejection Fraction
NCT06685237Heart Failure With Preserved Ejection Fraction (HFPEF)
Tor Biering-Sørensen
Observational
5,000
Hellerup
2025-02-28
Active, closed
Novo Nordisk A/S
Phase 3
400
Aarhus, Esbjerg, Hellerup, Hvidovre, Køge
2025-02-10
Recruiting
Herlev and Gentofte Hospital
Not applicable
936
Hellerup
2024-12-05
Recruiting
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
NCT07263490Pre-eclampsia, Oocyte Donation, Pre-Eclampsia; Complicating Pregnancy, Pre-Eclampsia; Mild
Copenhagen University Hospital, Hvidovre
Observational
462
Copenhagen, Hellerup, Herlev, København S, København Ø, Søborg
2024-10-21
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Hellerup, Odense C
2024-09-26
Recruiting
Aalborg University Hospital
Not applicable
1,616
Aalborg, Aarhus, Copenhagen, Hellerup, Odense, Roskilde
2024-08-28
By invitation
Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions
NCT06435494Shoulder Disease, Shoulder Impingement, Shoulder Osteoarthritis, Shoulder Frozen
University Hospital, Gentofte, Copenhagen
Not applicable
1,000
Gentofte Municipality, Rødovre Municipality, Charlottenlund, Hellerup
2024-08-12
Active, closed
Celldex Therapeutics
Phase 3
963
Aarhus N, Copenhagen NV, Hellerup
2024-07-11
Active, closed
AbbVie
Phase 3
1,400
Hellerup, Aarhus, Roskilde
2024-06-27
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Hellerup, Aalborg, Aarhus N, Gistrup, Hillerød, København Ø, Odense C, Svendborg
2024-06-25
Active, closed
Sanofi
Phase 2
185
Hellerup, Vejle
2024-06-20
Recruiting
Tor Biering-Sørensen
Not applicable
1,428
Hellerup
2024-05-31
Recruiting
Tor Biering-Sørensen
Not applicable
852
Hellerup
2024-03-26
Active, closed
University Hospital, Gentofte, Copenhagen
Not applicable
9
Hellerup
2024-02-21
Recruiting
Tor Biering-Sørensen
Phase 4
32,706
Hellerup
2024-01-15
Recruiting
The Role of Oxytocin in Regulating Blood Glucose
NCT06334172Glucose Metabolism Disorders (Including Diabetes Mellitus)
DrugOxytocin
University Hospital, Gentofte, Copenhagen
Not applicable
20
Hellerup
2024-01-01
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Aarhus, Odense C, Copenhagen, Hellerup
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Aarhus, Odense C, Hellerup
2023-09-14
Active, closed
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
NCT05949281Type 1 Diabetes, Cardiovascular Diseases, Chronic Inflammation
DrugColchicine
Asger Lund, MD
Phase 2
102
Hellerup
2023-08-29
Active, closed
HIDRAdenitis Suppurativa and HEART Disease
NCT05989945Hidradenitis, Hidradenitis Suppurativa, Hidradenitis Suppurativa, Familial, Left Ventricular Dysfunction
Herlev and Gentofte Hospital
Observational
250
Hellerup
2023-08-01
Recruiting
The COLchicine and Atrial FIBrillation Trial
NCT05928728Atrial Fibrillation
DrugColchicine
Herlev and Gentofte Hospital
Phase 3
500
Hellerup
2023-07-03
Recruiting
Radboud University Medical Center
Observational
100
Aarhus, Hellerup
2023-07-01
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Aalborg, Hellerup, Hvidovre, Odense C, Roskilde, Vejle
2023-06-28
Active, closed
Dapiglutide for the Treatment of Obesity
NCT05788601Obesity, Inflammation
University Hospital, Gentofte, Copenhagen
Phase 2
54
Hellerup
2023-04-27
Recruiting
University of Southern Denmark
Not applicable
280
Aabenraa, Aalborg, Aarhus, Hellerup, Odense, Roskilde
2023-03-13
Recruiting
Arthroscopic vs. Open Bone Grafting for Scaphoid Delayed/Nonunion
NCT05574582Scaphoid Fracture, Scaphoid Nonunion
Herlev and Gentofte Hospital
Not applicable
88
Hellerup
2023-02-15
Active, closed
Cardiac Structure and Function in Patients with Cystic Fibrosis
NCT06084468Cystic Fibrosis, Cystic Fibrosis-related Diabetes, Cystic Fibrosis, Pulmonary, Cystic Fibrosis of Pancreas
Herlev and Gentofte Hospital
Observational
104
Hellerup, Copenhagen
2023-01-01
Recruiting
Montreal Heart Institute
Phase 3
10,000
Hellerup
2022-12-21
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Hellerup, Kobenhavn N V
2022-12-09
Active, closed
University of Aarhus
Not applicable
84
Aarhus, Aarhus N, Copenhagen, Hellerup, Herning, Odense, Silkeborg, Vejle
2022-11-25
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Køge, Esbjerg, Aarhus N, Hellerup, Hvidovre
2022-11-01
Recruiting
Nils Hoyer
Observational
50
Hellerup
2022-09-18
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Aarhus N, Hellerup, Odense C
2022-09-06
Recruiting
Migration and Functional Outcome of DELTA Xtend Reverse Shoulder Lateralized Glenosphere Line Extension System
NCT05447819Rotator Cuff Arthropathy or Degeneration of the Glenohumeral Joint with Severe Posterior Wear
Herlev and Gentofte Hospital
Not applicable
122
Hellerup
2022-08-01
Recruiting
Danish Prostate Cancer Consortium Study-1
NCT05767307Prostate Cancer
Aarhus University Hospital
Observational
2,500
Aarhus N, Hellerup, Odense
2022-08-01
Recruiting
Rikke Sorensen
Phase 4
2,808
Aalborg, Copenhagen, Hellerup, Odense, Roskilde, Skejby
2022-06-17
Recruiting
The Organ Transplant Recipient HPV and Skin Cancer Study
NCT05284877Solid Organ Transplant Recipient, Skin Cancer, Skin Dysplasia, HPV Infection
Merete Haedersdal
Observational
1,500
Copenhagen NV, Hellerup, Roskilde
2022-03-10
Recruiting
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
NCT04950218Psoriasis, Cardiovascular Diseases, Cardiovascular Risk Factor, Cardiovascular Pathology
Herlev and Gentofte Hospital
Observational
1,000
Hellerup
2021-09-01
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Aarhus, Esbjerg, Gistrup, Hellerup, Herning, Odense, Roskilde, Svendborg
2021-08-14
Active, closed
The COlchicine HypERtENsion Trial
NCT04916522Hypertension
DrugColchicine
Herlev and Gentofte Hospital
Phase 2
150
Hellerup
2021-08-10
Recruiting
SCAD : a Registry of Spontaneous Coronary Artery Dissection
NCT06601270Spontaneous Coronary Artery Dissection
European Society of Cardiology
Observational
1,500
Aarhus, Copenhagen, Hellerup, Odense
2021-01-30
Active, closed
Galderma R&D
Phase 3
500
Aarhus, Hellerup
2021-01-11
Active, closed
The Relationship Between Inflammatory ARTritis and CArdiac DIseAse
NCT05647577Inflammatory Arthritis, Rheumatoid Arthritis, Spondylitis, Ankylosing, Axial Spondyloarthritis
University Hospital, Gentofte, Copenhagen
Observational
1,285
Hellerup
2021-01-01
Active, closed
SAFIR Family Talk - Investigating the Effect of The Family Talk Intervention
NCT05615324Mental Disorder, Family, Child, Parenting
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Not applicable
800
Hellerup
2020-08-01
Recruiting
Cohort of IPF Patients Experiencing an Exacerbation
NCT04442711Idiopathic Pulmonary Fibrosis
University Hospital, Gentofte, Copenhagen
Observational
50
Hellerup
2020-06-13
Recruiting
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NCT03563417Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery
Aarhus University Hospital Skejby
Not applicable
1,560
Aarhus N, Copenhagen, Hellerup, Odense, Roskilde
2018-11-06
Active, closed
Copenhagen University Hospital, Rigshospitalet
Not applicable
66
Hellerup
2018-08-01
Active, closed
Janssen-Cilag International NV
Observational
135
Copenhagen, Hellerup
2017-10-25
By invitation
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
NCT02796937Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
Grifols Therapeutics LLC
Phase 3
290
Arhus C, Hellerup
2016-07
Active, closed
Nils Hoyer
Observational
450
Hellerup, Aarhus
2016-04
Active, closed
Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay
NCT02772549Idiopathic Pulmonary Fibrosis
Nils Hoyer
Observational
300
Hellerup, Aarhus
2016-03
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Copenhagen, Hellerup, Hillerød, Odense
2012-01
Recruiting
Medtronic
Observational
20,000
Aarhus, Copenhagen, Hellerup, Hillerød, Odense
1983-01
Rows per page Showing 1–77 of 77
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/hellerup

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 77 of those studies with a site in Hellerup.

How many clinical trials are recruiting in Hellerup?

35 of the 77 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 5 have not yet opened recruitment, 31 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hellerup), 77 studies
PhaseStudiesRecruitingShare
Phase 326833.8%
Not applicable191024.7%
Observational181123.4%
Phase 48410.4%
Phase 2627.8%

Most active sponsors

Lead sponsors with the most studies (Hellerup)
Lead sponsorStudiesRecruiting
Tor Biering-Sørensen95
Herlev and Gentofte Hospital85
University Hospital, Gentofte, Copenhagen83
Novo Nordisk A/S52
Bristol-Myers Squibb41
Nils Hoyer31
Asger Lund, MD20
Celldex Therapeutics20
Copenhagen Respiratory Research22
Medtronic22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.